In Vivo is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Philips Healthcare

Division of Royal Philips NV
https://www.usa.philips.com/healthcare

Latest From Philips Healthcare

Exec Chat: Philips' Bert Van Meurs Discusses Innovation And Plans For Image-Guided Therapy Business Unit

This year, Bert van Meurs, chief business leader of Philips' image-guided therapy business, has led two major product launches and a new partnership with Microsoft to combine Philips' Azurion angiographic platform with Microsoft's HoloLens 2 mixed-reality (MR) technology. Medtech Insight caught up with van Meurs to learn more about Azurion, the continued role of machine learning and MR, the overall business strategy and competitive landscape.

Exec Chat Innovation

Global Device Approvals Snapshot: 4-10 June 2019

A snapshot of global medical device approvals captured during the past week in Medtech Insight's Approvals Tracker. This week’s approvals include the FDA’s approval of new non-adjunctive labeling for Senseonics’ Eversense continuous glucose monitor and a de novo for Innovative Health Solutions’ IB-Stim percutaneous electrical nerve field stimulator to treat pain associated with irritable bowel syndrome.

Approvals Innovation

Turkey’s $10Bn Medtech Tender Must Come With Export And Local IP Elements

Turkey’s health ministry has disclosed that the forthcoming $10bn medical device tender must come with conditions that strengthen the local manufacturing infrastructure. It must also give Turkey “real” technology with IP rights, not merely an assembly activity for parts manufactured abroad. The tender will be ready in some two to three months.

Turkey Policy

Seeing The Light: Philips’ Non-Pharma Solution To Reduce Delirium In The ICU

Philips’ VitalMinds concept is a multi-modal therapeutic solution to help hospitals reduce delirium and improve patient recovery in the ICU. A key new component, the VitalSky personalized light therapy system, has just been CE-marked, providing circadian-effective light therapy and producing a light and sound management solution that could become the new non-pharma standard.

Commercial Innovation
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register